PRP Injections for Thumb Arthritis: Does Platelet-Rich Plasma Work for CMC Joint Pain?
- Mar 2
- 5 min read
Written by Dr. Jeffrey Peng, MD — Board-Certified Sports Medicine Physician
Published: March 2, 2026 | Last Updated: March 2, 2026
Thumb arthritis at the carpometacarpal (CMC) joint is one of the most common and debilitating forms of hand osteoarthritis. This small but critical joint at the base of the thumb enables grasping, pinching, and fine motor tasks — and when arthritis sets in, it can significantly diminish quality of life. Many patients find that traditional treatments like splinting or cortisone injections provide only temporary or partial relief. Platelet-rich plasma (PRP) injections have been gaining attention as a potential non-surgical alternative, but does the evidence actually support their use? In this article, I review the latest systematic review and meta-analysis examining PRP for thumb CMC osteoarthritis to help you understand what the research shows and what it may mean for your treatment options.
Watch the Full Video
What Is Thumb Carpometacarpal Osteoarthritis?
Thumb carpometacarpal osteoarthritis affects the joint at the base of the thumb where it meets the wrist. This joint is essential for a wide range of daily activities because it allows the thumb to move in multiple directions, making it possible to grasp objects, pinch, turn keys, open jars, and hold a pen. It is one of the most common sites for osteoarthritis in the hand, particularly in women over the age of 50.
As the cartilage lining the joint surfaces wears down over time, the bones begin to rub against each other, leading to pain, swelling, stiffness, and sometimes visible deformity at the thumb base. Because the thumb is involved in so many daily activities, arthritis here can have an outsized impact on hand function and overall quality of life compared to arthritis in other small joints.
Traditional Treatment Options for Thumb Arthritis
Standard non-surgical approaches for thumb CMC arthritis include splinting to support and stabilize the joint, oral anti-inflammatory medications to manage pain and swelling, and corticosteroid injections for temporary symptom relief. In more advanced cases, surgical options such as joint reconstruction (trapeziectomy), fusion (arthrodesis), or joint replacement may be considered.
In my practice, I often see patients who have tried splinting and cortisone injections but continue to experience significant pain and functional limitations. While corticosteroid injections can provide short-term relief, their effects tend to diminish over time and repeated injections may carry risks to the surrounding soft tissues. This is one of the reasons newer biologic treatments like platelet-rich plasma (PRP) are being explored as an alternative option for patients with thumb arthritis.
What Is PRP and How Does It Work for Joint Arthritis?
Platelet-rich plasma is an autologous treatment made from the patient's own blood. A small blood sample is drawn and then spun in a centrifuge to concentrate the platelets and growth factors that circulate naturally in the body. When injected into an arthritic joint, these concentrated growth factors work to reduce inflammation, promote tissue repair, and may help support the health of remaining cartilage. The goal of PRP is to shift the joint environment from one that is chronically inflamed and degenerating to one that favors healing and biological balance.
PRP has been studied extensively in larger joints such as the knee and hip, where it has shown promising results for reducing pain and improving function. More recently, researchers have turned their attention to smaller joints like the thumb CMC joint to determine whether PRP can offer similar benefits in this challenging location.
What Does the Latest Research Show About PRP for Thumb Arthritis?
A comprehensive systematic review and meta-analysis published in 2025 by El Sewify et al. (2025) in the Journal of Hand and Microsurgery brought together the latest evidence on PRP injections for thumb CMC osteoarthritis. This review included seven studies with a total of 115 patients receiving PRP treatment. The majority of patients were around 62 years of age and predominantly female (67%), reflecting the typical demographic for this condition. Arthritis severity ranged across the studies, though most patients had moderate to advanced disease.
Patients received an average of approximately 1.4 PRP injections per thumb joint, typically spaced about three weeks apart, and were followed for an average of over 14 months to evaluate outcomes. The studies used various image-guidance techniques such as ultrasound or fluoroscopy to ensure accurate needle placement within this small joint. Control groups across the included studies received corticosteroids, normal saline, or hyaluronic acid injections for comparison.
Key Findings: Pain Relief, Hand Function, and Safety
The results of the meta-analysis were encouraging on several fronts. Across nearly 100 patients studied for pain outcomes, PRP injections led to a statistically significant reduction in pain scores. This means that, on average, patients experienced meaningful relief from the persistent thumb pain that limits everyday activities like gripping and pinching.
Functionally, PRP also improved hand performance. Patients demonstrated improved pinch strength, which is a critical measure for tasks that require fine motor control of the thumb. However, overall grip strength did not show a statistically significant change, likely because grip relies on the entire hand and forearm rather than the CMC joint alone.
Patient satisfaction was notably high, with approximately 74% of patients reporting that they were satisfied with their outcomes. All PRP-treated patients in the review were able to resume their prior activities of daily living after treatment. In terms of safety, PRP was very well tolerated — no adverse events were reported, with only a single complication (a palmar wrist ganglion) documented across all the studies.
What Does This Mean for Patients with Thumb Arthritis?
These findings suggest that PRP injections represent a promising non-surgical treatment option for thumb CMC osteoarthritis, offering meaningful pain relief and functional improvement with a strong safety profile. This is particularly relevant for patients who have found that corticosteroid injections provide only temporary benefit or who wish to explore alternatives before considering surgery.
Compared to traditional corticosteroid injections, which often provide only short-term relief that diminishes with repeated use, PRP may offer longer-lasting benefits by addressing the underlying inflammatory and degenerative processes within the joint. However, it is important to note that the research is still evolving. One of the major challenges highlighted in this review is the lack of standardized protocols for preparing and administering PRP, which leads to variability in results across studies. Different PRP preparations, injection frequencies, and guidance techniques make direct comparisons between studies more difficult.
In my practice, I discuss PRP as one of several treatment options for patients with thumb arthritis, particularly when conservative measures have not provided adequate relief. The decision to proceed with PRP should be made on an individual basis after a thorough evaluation of the patient's condition, arthritis severity, functional goals, and treatment history. As more randomized controlled trials are completed, we will gain a clearer picture of where PRP fits best in the treatment algorithm for thumb CMC osteoarthritis.
References
El Sewify O, Datta S, Legler J, Sylvain M, Cheah A, Efanov JI. Safety and efficacy of platelet-rich plasma injections in basal thumb osteoarthritis; should we offer it or not? J Hand Microsurg. 2025;17(3):100223. doi: 10.1016/j.jham.2025.100223
Disclaimer: This content is for educational purposes only and does not substitute for professional medical advice. Always consult with a qualified healthcare provider before making decisions about your treatment. The information presented reflects the opinions of Dr. Jeffrey Peng and does not represent the views of any affiliated institutions.
Comments